Should you buy Viatris stock? (NASDAQ:VTRS). Let's see how it does in our automated value investing analysis system.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Viatris to reach your target.
Hmm, we can't give any reliable projection for Viatris's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.
None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!
| Advantages | Disadvantages |
|---|---|
|
|
| VTRS Price (Viatris stock price per share) |
$17.18 | |
| PE Ratio versus Sector | 26% lower than other Healthcare stocks | |
| PE Ratio versus Industry | 0% lower than other Drug Manufacturers - General stocks | |
| Dividend Yield | 3% (tax impact) | Shares Shorted | 38,610,690 |
Open-market buys and sells reported by Viatris's officers, directors, and 10% owners on SEC Form 4. Routine transactions (tax withholding, option exercises, and stock grants) are excluded -- these are discretionary trades only.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2024-11-11T00:00:00 | Campbell Paul (See Remarks) | Sell | 26,925 | $12.88 |
| 2024-09-12T00:00:00 | Malik Rajiv | Sell | 139,681 | $11.66 |
| 2024-09-12T00:00:00 | Malik Rajiv | Sell | 60,319 | $11.71 |
| 2024-08-30T00:00:00 | Malik Rajiv | Sell | 50,000 | $12.00 |
| 2024-08-28T00:00:00 | Malik Rajiv | Sell | 50,000 | $11.90 |
| 2024-08-23T00:00:00 | Malik Rajiv | Sell | 100,000 | $11.75 |
| 2024-08-22T00:00:00 | Malik Rajiv | Sell | 100,000 | $11.73 |
| 2024-08-21T00:00:00 | Malik Rajiv | Sell | 100,000 | $11.75 |
| 2024-06-14T00:00:00 | Malik Rajiv | Sell | 264,300 | $10.18 |
| 2024-06-13T00:00:00 | Malik Rajiv | Sell | 85,660 | $10.52 |
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 38,610,690 shares shorted. With 1,141,791,206 shares available for purchase and an average trading volume over the past 10 trading days of 8,420,730, it would take at least 4.585 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
Based on our analysis, we believe that you should not buy Viatris right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.
Advertisement supports free stock analysis content.
Does Viatris have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to VTRS: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles